Skip to content
Search

Latest Stories

Assisted dying bill debate: Things pharmacy professionals should consider

pharmacy professionals are encouraged to take part in the assisted dying bill debate
Euthanasia, conceptual image (gettyimages)

Pharmacy professionals are advised to avoid directly engaging patients in the assisted dying bill debate

As the assisted dying bill moves through Parliament, pharmacy professionals are encouraged to take part in the public debate.

The UK chief pharmaceutical officers (CPhOs) – Andrew Evans (Wales), Alison Strath (Scotland), Cathy Harrison (Northern Ireland), David Webb (England) – have issued advice for pharmacists and pharmacy technicians wishing to give their opinions on this important topic.


“In our view it is entirely reasonable for any pharmacists and pharmacy technicians to give their opinions, and that the public would expect that,” they said in a statement released along with Elizabeth Fidler, senior professional advisor for pharmacy technician practice at NHS England, and Richard Cattell, deputy chief pharmaceutical officer for England.

However, pharmacy professionals are advised to avoid identifying individuals they have cared for unless with their consent and directly engaging patients in the debate.

The guideline also emphasised that pharmacists and pharmacy technicians should express their personal views, and not speak for the professions.

The CPhOs noted that the final decision on assisted dying must be made by society as a whole, through the parliamentary.

Despite the diverse views on the issue, the CPhOs believe the pharmacy professionals are united on two things:

  • that we must not undermine the provision of good end-of-life care for all including the outstanding work done by palliative care clinicians
  • that individual pharmacists and pharmacy technicians, and other healthcare professionals, should be able to exercise freedom of conscience

“This will, we are sure, be common ground for all sides involved in this complex societal decision,” they said.

An assisted dying for terminally ill adults bill is also proceeding through the Scottish parliamentary process.

Fiona McIntyre, policy and practice lead at the Royal Pharmaceutical Society in Scotland, recently presented evidence to the Health, Social Care and Sport Committee at the Scottish Parliament as part of its inquiry into the bill.

In her testimony, McIntyre highlighted that pharmacists and other healthcare professionals should have the ability to express their right to conscientiously object to any assisted death.

Fiona also stressed the importance of ensuring that any part of the assisted dying process, such as preparation or supply of the substance, which requires the input of a healthcare professional, should be covered by the requirement to opt-in.

A House of Commons debate on a Private Members' Bill on assisted dying is scheduled for Friday, 29 November.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less